NPI 1902008832: Open Payments
NPI 1902008832. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57 in 2 payments from 2 companies in 2025. Trend: 2023 $5,537 · 2024 $252 · 2025 $57
Food & beverage: $57
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $32 |
| ViiV Healthcare Company | 1 | $25 |
Products named: DOVATO.
